Cargando…
Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary ar...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724418/ https://www.ncbi.nlm.nih.gov/pubmed/33335708 http://dx.doi.org/10.1177/2045894020941343 |
_version_ | 1783620532255588352 |
---|---|
author | Amsallem, Myriam Bagherzadeh, Shadi P. Boulate, David Sweatt, Andrew J. Kudelko, Kristina T. Sung, Yon K. Feinstein, Jeffrey A. Fadel, Elie Mercier, Olaf Denault, Andre Haddad, Francois Zamanian, Roham |
author_facet | Amsallem, Myriam Bagherzadeh, Shadi P. Boulate, David Sweatt, Andrew J. Kudelko, Kristina T. Sung, Yon K. Feinstein, Jeffrey A. Fadel, Elie Mercier, Olaf Denault, Andre Haddad, Francois Zamanian, Roham |
author_sort | Amsallem, Myriam |
collection | PubMed |
description | The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary arterial hypertension. Patients with confirmed idiopathic, familial, drug and toxins, or connective tissue disease-related pulmonary arterial hypertension and at least one complete right heart catheterization were included and prospectively followed-up for 5.9 ± 4.03 years. Correlates of the primary end point (i.e. death or lung transplant need) during follow-up were determined using Cox regression modeling. Results showed that among the 308 patients included, 187 had at least one follow-up catheterization (median time between catheterizations: 2.16 (1.16–3.19) years). In the total cohort (mean age 47.3 ± 14.9 years, 82.8% of female and 58.1% in New York Heart Association class 3 or 4), mean pulmonary arterial pressure/mean arterial pressure (1.38 (1.07–1.77)) was associated with outcome (p = 0.01). Mean pulmonary arterial pressure/mean arterial pressure was incremental to a basic model (including right atrial pressure, systolic blood pressure, New York Heart Association class 3 or 4, and connective tissue disease) for outcome prediction, while mean pulmonary arterial pressure was not. In the 187 patients with a follow-up catheterization, both delta mean pulmonary arterial pressure and delta mean pulmonary arterial pressure/mean arterial pressure were associated with outcome (1.32 (1.11–1.58) and 1.31 (1.1–1.57) respectively, p < 0.01). Mean pulmonary arterial pressure and mean pulmonary arterial pressure/mean arterial pressure were both incremental to the basic model, while worsening in mean pulmonary arterial pressure or mean pulmonary arterial pressure/mean arterial pressure did not reach significance. In conclusion, mean pulmonary arterial pressure/mean arterial pressure at baseline prognosticates long-term outcome with a significant, albeit modest, incremental value to basic variables. |
format | Online Article Text |
id | pubmed-7724418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77244182020-12-16 Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension Amsallem, Myriam Bagherzadeh, Shadi P. Boulate, David Sweatt, Andrew J. Kudelko, Kristina T. Sung, Yon K. Feinstein, Jeffrey A. Fadel, Elie Mercier, Olaf Denault, Andre Haddad, Francois Zamanian, Roham Pulm Circ Original Research Article The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary arterial hypertension. Patients with confirmed idiopathic, familial, drug and toxins, or connective tissue disease-related pulmonary arterial hypertension and at least one complete right heart catheterization were included and prospectively followed-up for 5.9 ± 4.03 years. Correlates of the primary end point (i.e. death or lung transplant need) during follow-up were determined using Cox regression modeling. Results showed that among the 308 patients included, 187 had at least one follow-up catheterization (median time between catheterizations: 2.16 (1.16–3.19) years). In the total cohort (mean age 47.3 ± 14.9 years, 82.8% of female and 58.1% in New York Heart Association class 3 or 4), mean pulmonary arterial pressure/mean arterial pressure (1.38 (1.07–1.77)) was associated with outcome (p = 0.01). Mean pulmonary arterial pressure/mean arterial pressure was incremental to a basic model (including right atrial pressure, systolic blood pressure, New York Heart Association class 3 or 4, and connective tissue disease) for outcome prediction, while mean pulmonary arterial pressure was not. In the 187 patients with a follow-up catheterization, both delta mean pulmonary arterial pressure and delta mean pulmonary arterial pressure/mean arterial pressure were associated with outcome (1.32 (1.11–1.58) and 1.31 (1.1–1.57) respectively, p < 0.01). Mean pulmonary arterial pressure and mean pulmonary arterial pressure/mean arterial pressure were both incremental to the basic model, while worsening in mean pulmonary arterial pressure or mean pulmonary arterial pressure/mean arterial pressure did not reach significance. In conclusion, mean pulmonary arterial pressure/mean arterial pressure at baseline prognosticates long-term outcome with a significant, albeit modest, incremental value to basic variables. SAGE Publications 2020-12-06 /pmc/articles/PMC7724418/ /pubmed/33335708 http://dx.doi.org/10.1177/2045894020941343 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Amsallem, Myriam Bagherzadeh, Shadi P. Boulate, David Sweatt, Andrew J. Kudelko, Kristina T. Sung, Yon K. Feinstein, Jeffrey A. Fadel, Elie Mercier, Olaf Denault, Andre Haddad, Francois Zamanian, Roham Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension |
title | Hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
title_full | Hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
title_fullStr | Hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
title_full_unstemmed | Hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
title_short | Hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
title_sort | hemodynamic trajectories and outcomes in patients with pulmonary
arterial hypertension |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724418/ https://www.ncbi.nlm.nih.gov/pubmed/33335708 http://dx.doi.org/10.1177/2045894020941343 |
work_keys_str_mv | AT amsallemmyriam hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT bagherzadehshadip hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT boulatedavid hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT sweattandrewj hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT kudelkokristinat hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT sungyonk hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT feinsteinjeffreya hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT fadelelie hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT mercierolaf hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT denaultandre hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT haddadfrancois hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension AT zamanianroham hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension |